Cases 1 - 10 of 380
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. et al v. ALVOGEN, INC.
as 2:2023cv03911
Plaintiff:
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC., BOEHRINGER INGELHEIM INTERNATIONAL GMBH and BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG
Defendant:
ALVOGEN, INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. et al v. ALVOGEN, INC.
as 3:2023cv03911
Plaintiff:
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC., BOEHRINGER INGELHEIM INTERNATIONAL GMBH and BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG
Defendant:
ALVOGEN, INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Apotex Inc. et al
as 1:2023cv00685
Plaintiff:
Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, Boehringer Ingelheim Corporation and others
Defendant:
Apotex Inc. and Apotex Corp.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Hetero USA Inc. et al
as 1:2023cv00048
Plaintiff:
Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, Boehringer Ingelheim Corporation and others
Defendant:
Hetero USA Inc., Hetero Labs Limited Unit-V and Hetero Labs Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Cipla Ltd. v. Boehringer Ingelheim Pharmaceuticals Inc. et al
as 1:2022cv00300
Plaintiff:
Cipla Ltd.
Defendant:
Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharma GmbH & Co. KG
Cause Of Action: 35 U.S.C. § 1 Patent Infringement
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. et al v. QILU PHARMA INC.
as 2:2021cv00564
Plaintiff:
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC., BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG and BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Defendant:
Qila Pharma Inc. and QILU PHARMA INC.
Cause Of Action: 35 U.S.C. § 271
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. et al v. QILU PHARMACEUTICAL CO., LTD. et al
as 3:2021cv01732
Plaintiff:
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC., BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG and BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Defendant:
QILU PHARMACEUTICAL CO., LTD. and QILU PHARMA INC.
Cause Of Action: 35 U.S.C. § 271
BOEHRINGER INGELHEIM PHARMACEUTICALS INC. et al v. HEC PHARM CO., LTD. et al
as 2:2020cv02545
Plaintiff:
BOEHRINGER INGELHEIM CORPORATION, BOEHRINGER INGELHEIM INTERNATIONAL GMBH, BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG and others
Defendant:
HEC PHARM USA and HEC PHARM CO., LTD.
Cause Of Action: 35 U.S.C. § 271
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mylan Pharmaceuticals Inc. et al
as 1:2020cv00090
Plaintiff:
Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG and others
Defendant:
Mylan Pharmaceuticals Inc., Mylan Inc. and Mylan Laboratories Limited
Cause Of Action: 35 U.S.C. § 271
Max Ridings, et al v. Boehringer Ingelheim, et al
as 20-1824
Defendant / Appellee:
Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim (USA) Corp., Boehringer Ingelheim Corporation and others
Defendant:
Matthew Hoesch, Scott Maurice, Jennifer Caskey and others
Plaintiff / Appellant:
Sue Ridings and Max Ridings
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
